Patrick F. Smith, PRESIDENT, INTEGRATED DRUG Development at Certara, Inc. (CERT), sold 8,236 shares at $22.29 ($182K) on 2022-04-04, disclosed to the SEC on 2022-04-05.
Open-market sale of $182k CERT by PRESIDENT, INTEGRATED DRUG Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.48 | 1,532 | $33K | 18.0% |
| 2 | $22.29 | 3,352 | $75K | 41.0% |
| 3 | $22.29 | 3,352 | $75K | 41.0% |
| Total | $22.14 avg | 8,236 | $182K | 100% |
| Filing → |
| CERT | SELL | 2024-02-21 | $90K | — | Filing → |
| CERT | SELL | 2023-06-06 | $823K | — | Filing → |
| CERT | SELL | 2022-11-14 | $32K | — | Filing → |